KR20090049897A - Tooth whitening composition containing cleansing capsule - Google Patents
Tooth whitening composition containing cleansing capsule Download PDFInfo
- Publication number
- KR20090049897A KR20090049897A KR1020070116252A KR20070116252A KR20090049897A KR 20090049897 A KR20090049897 A KR 20090049897A KR 1020070116252 A KR1020070116252 A KR 1020070116252A KR 20070116252 A KR20070116252 A KR 20070116252A KR 20090049897 A KR20090049897 A KR 20090049897A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- capsule
- tooth
- cleansing
- porous material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 88
- 239000002775 capsule Substances 0.000 title claims abstract description 52
- 230000002087 whitening effect Effects 0.000 title claims abstract description 32
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000011148 porous material Substances 0.000 claims abstract description 22
- 229940087305 limonene Drugs 0.000 claims abstract description 21
- 235000001510 limonene Nutrition 0.000 claims abstract description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 12
- 235000005979 Citrus limon Nutrition 0.000 claims description 9
- 244000131522 Citrus pyriformis Species 0.000 claims description 9
- -1 polyethylene Polymers 0.000 claims description 9
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000003799 water insoluble solvent Substances 0.000 claims description 6
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000001993 wax Substances 0.000 claims description 4
- 239000005995 Aluminium silicate Substances 0.000 claims description 3
- 239000004640 Melamine resin Substances 0.000 claims description 3
- 229920000877 Melamine resin Polymers 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 235000012211 aluminium silicate Nutrition 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000004203 carnauba wax Substances 0.000 claims description 3
- 235000013869 carnauba wax Nutrition 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 239000005011 phenolic resin Substances 0.000 claims description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- 239000004800 polyvinyl chloride Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- QOSATHPSBFQAML-UHFFFAOYSA-N hydrogen peroxide;hydrate Chemical compound O.OO QOSATHPSBFQAML-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims 2
- 229920001807 Urea-formaldehyde Polymers 0.000 claims 2
- 239000001506 calcium phosphate Substances 0.000 claims 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims 2
- 229940038472 dicalcium phosphate Drugs 0.000 claims 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims 2
- 239000002861 polymer material Substances 0.000 claims 2
- 239000000356 contaminant Substances 0.000 abstract description 26
- 239000003795 chemical substances by application Substances 0.000 abstract description 10
- 238000011109 contamination Methods 0.000 abstract description 6
- 230000002209 hydrophobic effect Effects 0.000 abstract description 5
- 238000009472 formulation Methods 0.000 description 50
- 230000000052 comparative effect Effects 0.000 description 24
- 239000000606 toothpaste Substances 0.000 description 20
- 229940034610 toothpaste Drugs 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 208000004509 Tooth Discoloration Diseases 0.000 description 5
- 206010044032 Tooth discolouration Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000036367 tooth discoloration Effects 0.000 description 5
- 229920002148 Gellan gum Polymers 0.000 description 4
- 235000010492 gellan gum Nutrition 0.000 description 4
- 239000000216 gellan gum Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- POJWUDADGALRAB-UHFFFAOYSA-N allantion Natural products NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0279—Porous; Hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 클렌징 캡슐을 함유하는 치아 미백용 조성물에 관한 것으로, 보다 상세하게는 치아 오염을 효과적으로 제거하기 위하여 미백성분으로서 오염물질 용해제 및 다공성 물질을 포함하는 클렌징 캡슐을 함유하는 치아 미백용 조성물에 관한 것이다. 본 발명에 따른 치아 미백용 조성물은 클렌징 캡슐에 포집된 리모넨에 의해 치면의 소수성 오염물질을 용해시키고, 용해된 오염물질을 다공성 물질에 흡착시켜 제거할 수 있어, 치아의 오염물질 제거에 매우 효과적이다.The present invention relates to a tooth whitening composition containing a cleansing capsule, and more particularly, to a tooth whitening composition containing a cleansing capsule containing a contaminant dissolving agent and a porous material as a whitening component in order to effectively remove tooth contamination. will be. The tooth whitening composition according to the present invention dissolves hydrophobic contaminants on the tooth surface by limonene collected in the cleansing capsule, and removes the dissolved contaminants by absorbing the porous contaminants, which is very effective in removing tooth contaminants. .
클렌징, 캡슐, 리모넨, 다공성 물질, 클렌징 캡슐 Cleansing, Capsules, Limonene, Porous Materials, Cleansing Capsules
Description
본 발명은 클렌징 캡슐을 함유하는 치아 미백용 조성물에 관한 것으로, 보다 상세하게는 치아 오염을 효과적으로 제거하기 위하여 미백성분으로서 오염물질 용해제 및 다공성 물질을 포함하는 클렌징 캡슐을 함유하는 치아 미백용 조성물에 관한 것이다. 본 발명에 따른 치아 미백용 조성물은 클렌징 캡슐에 포집된 리모넨에 의해 치면의 소수성 오염물질을 용해시키고, 용해된 오염물질을 다공성 물질에 흡착시켜 제거할 수 있어, 치아의 오염물질 제거에 매우 효과적이다.The present invention relates to a tooth whitening composition containing a cleansing capsule, and more particularly, to a tooth whitening composition containing a cleansing capsule containing a contaminant dissolving agent and a porous material as a whitening component in order to effectively remove tooth contamination. will be. The tooth whitening composition according to the present invention dissolves hydrophobic contaminants on the tooth surface by limonene collected in the cleansing capsule, and removes the dissolved contaminants by absorbing the porous contaminants, which is very effective in removing tooth contaminants. .
현재까지 알려진 치아의 변색 요인은 치아 내부의 신경 손상, 노화 또는 테트라사이클린류와 같은 항생제의 과다 복용 등에 의해 발생되는 내인성 치아 변색과 치아 표면에 침착된 음식물의 찌꺼기 또는 담배의 니코틴 및 타르성분, 커피, 홍차 등에 의해 발생되는 외인성 치아 변색으로 나눌 수 있다. Known tooth discoloration factors are endogenous tooth discoloration caused by nerve damage inside the tooth, aging or overdose of antibiotics such as tetracyclines, and food residues deposited on the tooth surface or nicotine and tar components of tobacco, coffee It can be divided into exogenous tooth discoloration caused by black tea.
내인성의 치아 변색을 치료하기 위해서는 과산화물이 사용되고 있으며, 외인 성의 치아 변색을 치료하기 위해서 연마제가 배합되어 물리적으로 제거하거나, 계면활성제를 이용해서 화학적으로 제거하고 있다. Peroxides are used to treat endogenous tooth discoloration, and in order to treat exogenous tooth discoloration, abrasives are blended and physically removed or chemically removed using a surfactant.
한국공개특허공보 특2003-0044389호에서는 섬유에서의 오염물을 제거하기 위해서 계면활성제 이외에 리모넨을 함유하여 우수한 소수성 얼룩제거 효과를 나타낸다고 보고하였다. In Korean Patent Laid-Open No. 2003-0044389, it is reported that limonene is included in addition to the surfactant in order to remove contaminants from the fiber, thereby showing excellent hydrophobic stain removal effect.
치약 조성물에서도 리모넨이 사용되는 예가 있지만, 단순히 향의 일종으로서 사용되었으며, 오염을 제거하고자 하는 용도로 사용되고 있지는 않았다.Although limonene is also used in the toothpaste composition, it was merely used as a kind of fragrance and was not used to remove contamination.
치약 조성물에서 리모넨과 같은 오일성분이 다량 배합되면, 양치 중에 기포력이 저하되는 문제가 있어, 일본공개특허공보 평10-067625호에서는 리모넨 등의 친유성 성분을 젤란검(gellan gum)을 주성분으로 하는 피막으로 포집한 캡슐을 포함하는 구강용 조성물이 언급되어 있다. 이 발명은 친유성 성분을 치약 제형내에서 안정하게 유지하고자 할 뿐이었기 때문에, 클렌징 효과를 올리기 위한 고려는 없었다.When a large amount of an oil component such as limonene is blended in the dentifrice composition, there is a problem of deterioration of bubble power during brushing. In Japanese Patent Laid-Open No. 10-067625, a lipophilic component such as limonene is mainly composed of gellan gum. There is mentioned a composition for oral cavity comprising a capsule collected into a coating. Since this invention only intended to keep the lipophilic component stable in the toothpaste formulation, there was no consideration for enhancing the cleansing effect.
이에 본 발명자들은 치아의 외인성 착색에 의한 오염을 효과적으로 제거하기 위한 방법을 연구하던 중 미백성분으로서 오염물질 용해제와 다공성 물질을 포함하는 클렌징 캡슐을 제조한 후 이를 구강용 조성물에 적용할 경우 클렌징 캡슐에 포집된 오염물질 용해제에 의해 치면의 소수성 오염물질이 용해되고, 용해된 오염물질을 다공성 물질에 흡착되어 제거되는 것을 확인하고 본 발명을 완성하게 되었다.Therefore, the present inventors have been studying a method for effectively removing the contamination caused by the exogenous pigmentation of the tooth, while preparing a cleansing capsule containing a contaminant dissolving agent and a porous material as a whitening component and applying it to the oral composition, Hydrophobic contaminants on the tooth surface were dissolved by the collected contaminant solubilizer, and the dissolved contaminants were adsorbed and removed from the porous material, thereby completing the present invention.
따라서, 본 발명의 목적은 치아의 외인성 착색에 의한 오염을 효과적으로 제거하는 치아 미백용 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a composition for whitening teeth which effectively removes contamination by exogenous coloring of teeth.
상기 목적을 달성하기 위하여, 본 발명에서는 치아 미백성분으로서 오염물질 용해제와 다공성 물질을 포함하는 클렌징 캡슐을 함유하는 치아 미백용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for whitening teeth comprising a cleansing capsule containing a contaminant dissolving agent and a porous material as a tooth whitening component.
본 발명에 따른 치아 미백용 조성물은 클렌징 캡슐에 포집된 오염물질 용해제에 의해 치면의 소수성 오염물질을 효과적으로 용해시키고, 용해된 오염물질이 다공성 물질에 흡착되어 제거됨으로써 치아의 오염 제거에 매우 효과적이었다.The tooth whitening composition according to the present invention was very effective in dissolving hydrophobic contaminants on the tooth surface by the contaminant dissolving agent collected in the cleansing capsule, and the dissolved contaminants were adsorbed on the porous material to remove the contaminants.
이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에 의한 클렌징 캡슐은 미백성분으로서 오염물질 용해제 및 다공성 물질을 포함한다.The cleansing capsule according to the present invention includes a contaminant dissolving agent and a porous material as a whitening ingredient.
본 발명에서 치아의 오염물질을 화학적으로 제거하기 위한 오염물질 용해제로는 리모넨 또는 리모넨이 다량 함유되어 있는 레몬 또는 오렌지 등의 추출물이 사용 될 수 있다. In the present invention, as a contaminant dissolving agent for chemically removing contaminants of teeth, extracts such as lemon or orange containing a large amount of limonene or limonene may be used.
본 발명에서 사용하는 레몬 또는 오렌지 추출물은 과피를 건조한 후 건조 과피 1kg당 20∼95% 에탄올 3 내지 30L를 가하고, 25∼80℃에서 1 내지 12 시간 동안 추출한 다음 이 추출물을 여과한 후 여액을 진공농축하여 제조한 것이다.The lemon or orange extract used in the present invention is dried and then added to 3 to 30L of 20 to 95% ethanol per kg of dried skin, extracted at 25 to 80 ° C. for 1 to 12 hours, and then the extract is filtered and the filtrate is vacuumed. It is prepared by concentration.
상기 오염물질 용해제의 함량은 캡슐 총 중량에 대하여 0.1∼30 중량%가 바람직하며, 용해제의 함량이 0.1 중량% 미만인 경우에는 클렌징 캡슐의 오염물질에 대한 용해력이 너무 낮아 실질적인 오염 제거 효과가 없고, 30 중량%를 초과하는 경우에는 캡슐의 강도가 너무 낮아 치약 제조시에 캡슐이 모두 붕괴되는 문제가 발생한다.The content of the contaminant dissolving agent is preferably 0.1 to 30% by weight based on the total weight of the capsule, and when the content of the dissolving agent is less than 0.1% by weight, the dissolving power of the cleansing capsule is too low to have a substantial decontamination effect. If the weight percentage is exceeded, the strength of the capsule is so low that there is a problem that all capsules collapse during toothpaste preparation.
본 발명에서 사용하는 다공성 물질로는 입자크기가 5∼600㎛, 바람직하게는 10∼400㎛인 다공성 물질, 특히 일차입자의 크기가 1∼100㎚인 다공성 물질을 사용한다. 이러한 다공성 물질의 예로는 실리카, 탄산칼슘, 제이인산칼슘, 수산화알루미늄 및 카올린 등과 같은 무기 분체 뿐만 아니라 폴리에틸렌, 폴리염화비닐, 폴리에스테르, 폴리스티렌, 폴리프로필렌, 폴리아미드, 폴리카보네이트, 페놀수지, 요 소수지, 폴리메틸메타크릴레이트수지 및 멜라민수지와 같은 고분자물질도 사용될 수 있다. As the porous material used in the present invention, a porous material having a particle size of 5 to 600 µm, preferably 10 to 400 µm, in particular, a porous material having a primary particle size of 1 to 100 nm is used. Examples of such porous materials include inorganic powders such as silica, calcium carbonate, dibasic calcium phosphate, aluminum hydroxide and kaolin, as well as polyethylene, polyvinyl chloride, polyester, polystyrene, polypropylene, polyamide, polycarbonate, phenolic resin, Polymeric materials such as paper, polymethyl methacrylate resin and melamine resin can also be used.
상기 다공성 물질의 함량은 캡슐 총 중량에 대하여 5∼70 중량%가 바람직하며, 다공성 물질의 함량이 5 중량% 미만인 경우에는 용해된 오염물질이 충분히 흡착되어 제거되지 못하는 문제가 발생하고, 70 중량%를 초과하는 경우에는 캡슐 외벽의 코팅제의 함량이 너무 낮아져 캡슐을 충분히 코팅하지 못하는 문제가 발생한다.The content of the porous material is preferably 5 to 70% by weight based on the total weight of the capsule, and when the content of the porous material is less than 5% by weight, there is a problem that the dissolved contaminants are not sufficiently adsorbed and removed, and 70% by weight. In the case of exceeding the content of the coating agent of the capsule outer wall is too low a problem that does not coat the capsule sufficiently.
본 발명의 바람직한 실시예에서는 다공성 실리카와 리모넨을 사용하여 클렌징 캡슐을 제조한다.In a preferred embodiment of the present invention, a cleansing capsule is prepared using porous silica and limonene.
한편, 본 발명에서는 상기 오염물질 용해제 및 다공성 물질을 비즈왁스와 같은 수불용성 용매에 혼합하여 유동층 과립기 또는 건조분무기 등을 사용하여 당업계에 잘 알려진 통상적인 방법에 의해 클렌징 캡슐을 제조할 수 있다.Meanwhile, in the present invention, the contaminant dissolving agent and the porous material may be mixed with a water insoluble solvent such as beeswax to prepare a cleansing capsule by a conventional method well known in the art using a fluidized bed granulator or a dry sprayer. .
본 발명에서 사용하는 클렌징 캡슐의 제조과정을 보다 상세히 살펴보면 하기와 같다:Looking at the manufacturing process of the cleansing capsule used in the present invention in more detail as follows:
1) 리모넨 또는 리모넨이 다량 함유되어있는 레몬 또는 오렌지 추출물(이하 "리모넨"이라 함) 및 다공성 물질을 수불용성 용매에 분산시켜 에멀젼 용액을 제조하는 단계; 및 1) preparing an emulsion solution by dispersing a lemon or orange extract (hereinafter referred to as "limonene") and a porous material containing a large amount of limonene or limonene in a water-insoluble solvent; And
2) 상기 에멀젼 용액을 분무건조기를 사용하여 구형태의 캡슐로 제조하는 단계;2) preparing the emulsion solution into a spherical capsule using a spray dryer;
를 포함하는 것을 특징으로 한다. Characterized in that it comprises a.
상기와 같은 리모넨 및 다공성 물질을 균일하게 분산시키기 위한 분산매로는 상온에서 고체상을 나타내는 수불용성의 물질을 사용할 수 있다. 이러한 수불용성 물질로는, 바람직하게는 왁스나 오일을 사용할 수 있으며, 더욱 바람직하게는 카르나우바왁스, 비스왁스, 파라핀왁스, 동물성 스테아린산염, 코코넛오일 및 팜유 등으로 구성된 군으로부터 1종 이상을 선택하여 사용할 수 있다. As a dispersion medium for uniformly dispersing the limonene and the porous material as described above, a water-insoluble material that exhibits a solid phase at room temperature may be used. As such a water-insoluble substance, preferably wax or oil can be used, and more preferably at least one selected from the group consisting of carnauba wax, bis wax, paraffin wax, animal stearate, coconut oil, palm oil and the like. Can be selected and used.
상기 제조된 클렌징 캡슐은 구강 조성물에 사용되는 것이기 때문에, 캡슐 자체의 경도가 너무 강한 경우에는 사용 중 구강점막에 손상을 줄 수 있으며, 이물감이 강하게 느껴질 수 있으므로, 클렌징 캡슐의 경도를 조절하기 위한 용도로 상기 수불용성 물질을 1종 이상 혼합하여 사용할 수 있다. Since the prepared cleansing capsule is used in the oral composition, if the hardness of the capsule itself is too strong, it may damage the oral mucosa during use, and a sense of foreign body may be felt strongly, and thus it is used for adjusting the hardness of the cleansing capsule. It may be used by mixing one or more of the water-insoluble substances.
상기의 방법 중 1)단계에서와 같이 제조한 리모넨 및 다공성 물질을 함유하는 에멀젼 용액을 구형태의 캡슐로 제조하기 위하여 본 발명에서는 분무건조기(spray drier)를 사용하였다. 일반적으로, 분무건조기는 특정성분이 용해되어 있는 용액을 분무시키면서 용매를 증발시키고 파우더 형태의 제품을 얻는데 사용되는 장치이다. 그러나, 본 발명에서 이용한 분무건조기는 용매를 증발시키는 것이 아니라 에멀젼 용액이 분사될 때 분무건조기의 챔버(chamber) 내부에서 자유낙하 하면서 냉각 및 건조되어 구형태를 형성하는 원리를 이용한 것이다. 이 때, 챔버 내부의 온도는 냉각 건조될 수 있는 온도면 모두 가능하나 바람직하게는 10∼20℃가 좋다. Spray drier was used in the present invention to prepare an emulsion solution containing limonene and a porous material prepared as in step 1) of the above method into a capsule in the form of a sphere. In general, a spray dryer is a device used to evaporate a solvent and obtain a powder form product while spraying a solution in which a specific component is dissolved. However, the spray dryer used in the present invention utilizes the principle of cooling and drying while free-falling in the chamber of the spray dryer when the emulsion solution is injected, rather than evaporating the solvent to form a spherical shape. At this time, the temperature inside the chamber may be any temperature that can be cooled and dried, but preferably 10 to 20 ° C.
상기 과정을 통하여 제조한 본 발명의 클렌징 캡슐은 평균 입자크기가 300∼600㎛이다.Cleansing capsule of the present invention prepared through the above process has an average particle size of 300 ~ 600㎛.
본 발명은 상기 클렌징 캡슐을 함유하는 치아 미백용 조성물에 관한 것으로서, 본 발명에 의한 치아 미백용 조성물은 상기 클렌징 캡슐을 조성물 총 중량에 대하여 0.05∼10 중량%로 함유하는 것이 바람직하며, 상기 클렌징 캡슐의 함량이 0.05 중량% 미만인 경우에는 실질적으로 오염을 제거하지 못하는 문제가 발생하고, 10 중량%를 초과하는 경우에는 치약 제형에서 캡슐의 함량이 너무 높아져 치약의 외관이 보기 좋지 않으며, 양치 시에 심한 이물감이 발생한다.The present invention relates to a composition for whitening teeth containing the cleansing capsule, wherein the composition for teeth whitening according to the present invention preferably contains the cleansing capsule at 0.05 to 10% by weight based on the total weight of the composition, and the cleansing capsule If the content of less than 0.05% by weight, the problem that can not remove the contamination substantially occurs, if the content of more than 10% by weight of the capsule in the toothpaste formulation is too high, the appearance of the toothpaste is not good, and when brushing Foreign object occurs.
또한 과산화수소수가 함유된 구강용 조성물에 본 발명에 의한 클렌징 캡슐을 적용하는 경우에도 외부 착색오염을 제거하는 효과가 뛰어나고 미백효과가 우수한 제형을 제조할 수 있다.In addition, even when the cleansing capsule according to the present invention is applied to the composition for oral cavity containing hydrogen peroxide water, it is possible to prepare a formulation having excellent effect of removing external staining and excellent whitening effect.
본 발명에 사용되는 치아 미백용 조성물의 다른 배합 성분은 위에서 기술한 클렌징 캡슐 외에도 조성물의 용도와 종류에 따라 당업자가 용이하게 선택하여 변경할 수 있다.Other compounding components of the tooth whitening composition used in the present invention can be easily selected and changed by those skilled in the art according to the use and type of the composition in addition to the cleansing capsules described above.
본 발명에서 실시하기 위한 각종 치약 조성물은 그 종류에 따라 적당한 성분을 사용해야 하는데 예를 들면 통상적인 치약성분들로서 연마제, 습윤제, 기포제, 결합제, 감미제, pH 조절제, 방부제, 약효성분, 향료, 증백제, 색소 및 용제 등을 함유할 수 있다. Various toothpaste compositions for carrying out the present invention should use appropriate ingredients according to the kind, for example, as a conventional toothpaste components, such as abrasives, wetting agents, foaming agents, binders, sweeteners, pH adjusting agents, preservatives, active ingredients, flavoring agents, brighteners, A dye, a solvent, etc. can be contained.
본 발명에서 사용하는 연마제로는 탄산칼슘, 침강 실리카, 수산화알루미늄, 인산일수소칼슘 및 불용성 메타인산나트륨 등이 있으나, 이에만 한정되는 것은 아니다. 이들 연마제는 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 1-60 중량%, 바람직하게는 10-50 중량%로 사용할 수 있다. The abrasive used in the present invention includes, but is not limited to, calcium carbonate, precipitated silica, aluminum hydroxide, calcium dihydrogen phosphate, insoluble sodium metaphosphate, and the like. These abrasives may be used alone or in admixture of two or more, 1-60% by weight, preferably 10-50% by weight, based on the total weight of the composition.
본 발명에서 사용하는 습윤제로는 글리세린, 소르비톨액, 폴리에틸렌글리콜 및 프로필렌글리콜 등이 있으나, 이에만 한정되는 것은 아니다. 이들 습윤제는 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 10-60 중량%, 바람직하게는 20-50 중량%로 사용할 수 있다. Wetting agents used in the present invention include, but are not limited to, glycerin, sorbitol liquid, polyethylene glycol and propylene glycol. These humectants may be used alone or in admixture of two or more, 10-60% by weight, preferably 20-50% by weight, based on the total weight of the composition.
본 발명에서 사용하는 기포제로는 라우릴황산나트륨, 소디움라우릴사르코시네이트, 자당지방산에스테르, 폴리옥시에틸렌경화피마자유 및 폴리옥시에틸렌폴리옥시프로필렌 공중합체 등의 음이온 및 비이온 계면활성제를 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 0.5-5 중량%, 바람직하게는 0.5-3 중량% 사용할 수 있다. As the foaming agent used in the present invention, anionic and nonionic surfactants such as sodium lauryl sulfate, sodium lauryl sarcosinate, sucrose fatty acid ester, polyoxyethylene-cured castor oil and polyoxyethylene polyoxypropylene copolymer alone or 2 It can mix 0.5 or more, and can use 0.5-5 weight% with respect to the total weight of a composition, Preferably 0.5-3 weight% is used.
본 발명에서 사용하는 결합제로는 카르복시메틸셀룰로오스 나트륨, 하이드록시메틸셀룰로오스, 카라기난, 잔탄검 및 알긴산 나트륨 등을 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 0.1-5 중량%, 바람직하게는 0.1-2 중량% 사용할 수 있다. As the binder used in the present invention, sodium carboxymethyl cellulose, hydroxymethyl cellulose, carrageenan, xanthan gum and sodium alginate may be used alone or in combination of two or more thereof, and 0.1-5% by weight, preferably 0.1- 2% by weight can be used.
본 발명에서 사용하는 감미제로는 삭카린나트륨, 아스파탐, 스테비오사이드, 자일리톨 및 감초산 등을 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 0.05-5 중량%를 사용할 수 있다. As the sweetener used in the present invention, 0.05-5% by weight of saccharin sodium, aspartame, stevioside, xylitol and licorice may be used alone or in combination of two or more kinds thereof.
본 발명에서 사용하는 pH 조절제로는 인산나트륨, 인산이나트륨, 인산삼나 트륨, 피로인산나트륨, 구연산, 구연산나트륨 및 주석산 등을 사용할 수 있고, 방부제로는 파라옥시안식향산메틸, 파라옥시안식향산프로필 및 안식향산나트륨을 단독 혹은 2종 이상 혼합하여 사용할 수 있다. As the pH adjusting agent used in the present invention, sodium phosphate, disodium phosphate, trisodium phosphate, sodium pyrophosphate, citric acid, sodium citrate and tartaric acid may be used. Preservatives include methyl paraoxybenzoate, propyl paraoxybenzoate and benzoic acid. Sodium may be used alone or in combination of two or more thereof.
본 발명에서 사용하는 약효성분으로는 불화나트륨, 일불소인산나트륨, 불화주석, 클로로헥시딘, 알란토인클로로히드록시알루미네이트, 아미노카프론산, 트라넥사민산, 트리클로산, 염화세틸피리디움, 염화아연, 염산피리독신 및 초산토코페롤 등을 단독 혹은 2종 이상 혼합하여 사용할 수 있고, 향료로는 페퍼민트오일, 스피아민트오일, 멘톨 및 아네톨 등을 적당량 혼합하여 사용할 수 있으며, 증백제로는 산화티탄을, 색소로는 식용색소를, 정제수 및 에탄올의 용제로 통상의 치약 제조방법에 따라 제조할 수 있다.The active ingredients used in the present invention include sodium fluoride, sodium monofluorophosphate, tin fluoride, chlorohexidine, allantoin chlorohydroxy aluminate, aminocaproic acid, tranexamic acid, trichloric acid, cetylpyrididium, zinc chloride , Pyridoxine hydrochloride, tocopherol acetate and the like can be used alone or in combination of two or more thereof.As a fragrance, peppermint oil, spearmint oil, menthol and anetol can be mixed in an appropriate amount. Furnace can be prepared in accordance with the conventional toothpaste manufacturing method in a solvent of purified water and purified water and ethanol.
이하, 실시예 및 제형예를 들어 본 발명에 따른 치아 미백용 조성물의 구성 및 작용효과에 대해 보다 구체적으로 설명한다. 그러나, 본 발명이 이들예로만 한정되는 것은 아니다. Hereinafter, the composition and effect of the tooth whitening composition according to the present invention will be described in more detail with examples and formulation examples. However, the present invention is not limited only to these examples.
[실시예 1] 클렌징 캡슐의 제조Example 1 Preparation of Cleansing Capsule
레몬 과피를 건조한 후 건조 과피 1kg당 95% 에탄올 10L를 가하고, 60℃에서 10시간 동안 추출한 다음 이 추출물을 여과한 후 여액을 진공농축하여 레몬 추출물을 얻었다.After drying the lemon peel, 10L of 95% ethanol was added per 1 kg of dried peel, extracted at 60 ° C. for 10 hours, and the extract was filtered and the filtrate was concentrated in vacuo to obtain a lemon extract.
비즈왁스 80g을 65-75℃로 가열하고, 여기에 실리카 과립 10g와 레몬 추출 물 10g을 첨가하고 교반하여 다공성 실리카 분체가 가라앉지 않도록 유지하였다. 제조된 혼합액을 분무건조기에 가하고 분무와 동시에 냉각, 건조함으로써 구 형태의 클렌징 캡슐 100g을 제조하였다. 본 발명에 사용된 캡슐은 완벽한 구형태로 300-600㎛의 입자크기를 갖는다. 80 g of beeswax was heated to 65-75 ° C., and 10 g of silica granules and 10 g of lemon extract were added thereto and stirred to keep the porous silica powder from sinking. 100 g of the spherical cleansing capsule was prepared by adding the prepared liquid mixture to a spray dryer and simultaneously cooling and drying the sprayer. Capsules used in the present invention have a particle size of 300-600 μm in perfect spherical form.
[실시예 2]Example 2
상기 실시예 1에서 레몬 추출물 대신에 리모넨을 사용한 것을 제외하고 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except that limonene was used instead of the lemon extract in Example 1.
[제형예 1∼3 및 비교제형예 1∼4] [Formulation Examples 1 to 3 and Comparative Formulation Examples 1 to 4]
하기 표 1의 처방에 의해 통상의 치약의 제조방법에 따라 제형예 1∼3 및 비교제형예 1∼4의 치약을 제조하였다. Toothpaste of Formulation Examples 1 to 3 and Comparative Formulation Examples 1 to 4 was prepared according to the method for preparing a toothpaste according to the formulation of Table 1 below.
제형예 1과 2에는 실시예 1에서 제조한 클렌징 캡슐을, 제형예 3에는 실시예 2에서 제조한 클렌징 캡슐을 첨가하였고, 비교제형예 2에는 클렌징 캡슐 대신에 리모넨과 다공성 실리카 과립을, 비교제형예 4에는 젤란검 캡슐을 첨가하였다. 상기에서 첨가한 젤란검 캡슐은 일본공개특허 평10-067625호에 기재된 방법에 따라 제조하였다.In Formulation Examples 1 and 2, the cleansing capsules prepared in Example 1 were added, and in Formulation Example 3, the cleansing capsules prepared in Example 2 were added. In Comparative Example 2, limonene and porous silica granules were used instead of the cleansing capsules. In Example 4 gellan gum capsules were added. Gellan gum capsules added above were prepared according to the method described in Japanese Patent Laid-Open No. 10-067625.
[시험예 1] 치아 미백 효과 측정(in vivo)[Test Example 1] Measurement of tooth whitening effect (in vivo)
본 발명에 따른 치아미백용 치약의 치아 미백 효과를 알아보기 위하여, 건강한 남녀 실험자 150명을 표본으로 선정하여 사용 전 후의 치아 색도를 측정하였다.In order to examine the tooth whitening effect of the toothpaste for tooth whitening according to the present invention, 150 healthy male and female experimenters were selected as samples and the tooth chromaticity before and after use was measured.
먼저, SHADEEYE-EX(SHOFU Co.LTD., Japan)를 사용하여 피실험자의 본래 치아 색조를 측정하였다. SHADEEYE-EX 팁을 상악 좌측 중절치 협면 치경부 상방 2mm, 근원심 중간의 치면에 빛이 외부로 새지 않게 직각으로 대고 광선을 조사하여 1차 기준값(baseline) 자료를 측정 및 수집한 후, 1개월 동안 상기 제조된 제형예 1∼3 및 비교제형예 1∼4의 치약으로 하루 3회씩 양치하도록 하였다. 시험기간 동안 자신의 평소 식습관대로 음식은 섭취하되, 색도를 측정하는 날의 색도측정 전에는 커피, 콜라 및 담배 등을 금지시켰다. 상기 제형예 1∼3 및 비교제형예 1∼4의 치약을 사용한지 2개월 후에 색도를 측정(2차 측정)하였으며, 그 결과를 각각 표 2 및 3에 나타내었다.First, the original tooth tone of the test subject was measured using SHADEEYE-EX (SHOFU Co.LTD., Japan). Place the SHADEEYE-EX tip 2 mm above the maxillary left central incisal buccal cervical region and at a right angle so that light does not leak out to the tooth surface in the middle of the mesial, irradiating light and measuring the primary baseline data. Toothpaste was prepared three times a day with the toothpaste of Formulation Examples 1 to 3 and Comparative Formulations 1 to 4 prepared. During the test, he was allowed to eat food according to his or her usual diet, but coffee, cola, and cigarettes were prohibited before chromaticity was measured on the day of chromaticity measurement. Two months after using the toothpaste of Formulation Examples 1-3 and Comparative Formulation Examples 1-4, the chromaticity was measured (secondary measurement), and the results are shown in Tables 2 and 3, respectively.
상기 표 2 및 3의 결과로부터, 제형예 1과 제형예 3의 치약이 비교제형예 1, 2, 4의 치약에 비하여 치아오염제거 효과가 뛰어났으며 이로 인한 미백효과가 우수함을 확인할 수 있었다. 또한 과산화수소수가 함유된 치약에서도 제형예 2의 치약이 비교제형예 3에 비하여 외부 착색오염의 제거 효과가 뛰어나 미백효과가 더 우수함을 확인할 수 있었다.From the results of Tables 2 and 3, the toothpaste of Formulation Example 1 and Formulation 3 was superior to the toothpaste removal effect compared to the toothpaste of Comparative Formulation Examples 1, 2, 4, it was confirmed that the whitening effect was excellent. In addition, in the toothpaste containing hydrogen peroxide solution, the toothpaste of Formulation Example 2 was found to have a superior whitening effect as compared to Comparative Formulation Example 3 with an excellent effect of removing external staining.
[시험예 2] 사용감 평가Test Example 2 Evaluation
상기 제형예 1∼2 및 비교제형예 1∼2의 치약을 타액으로 적신 칫솔에 1g씩 적용하고 30명의 실험자에게 3분간 양치질을 시킨 후 물로 5회 세척한 뒤 기포력과 쓴맛의 정도를 5점 척도로 양치 후에 측정하였으며, 그 결과를 하기 표 4에 나타내었다. 1 g of toothpaste of Formulation Examples 1 and 2 and Comparative Formulation Examples 1 and 2 were applied to the toothbrush soaked with saliva, and then brushed with 30 subjects for 3 minutes, washed 5 times with water, and then scored 5 points of bubble power and bitterness. Measured after brushing on a scale, the results are shown in Table 4 below.
상기 표 4의 결과에서 알 수 있는 바와 같이, 리모넨이 직접 첨가된 비교 제형예2에서의 기포력저하 및 쓴맛 증대가 나타났으며, 클렌징 캡슐을 포함하는 제형예 1∼2는 미백성분을 포함하지 않는 비교제형예 1과 기포력 및 쓴맛에 있어서 큰 차이가 없었다. As can be seen from the results of Table 4, the foaming power decrease and bitter taste increase in Comparative Formulation Example 2 to which limonene was added directly, Formulation Examples 1 to 2 including a cleansing capsule does not include a whitening component There was no significant difference in foaming power and bitter taste with Comparative Formulation Example 1.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070116252A KR20090049897A (en) | 2007-11-14 | 2007-11-14 | Tooth whitening composition containing cleansing capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070116252A KR20090049897A (en) | 2007-11-14 | 2007-11-14 | Tooth whitening composition containing cleansing capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090049897A true KR20090049897A (en) | 2009-05-19 |
Family
ID=40858515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020070116252A Ceased KR20090049897A (en) | 2007-11-14 | 2007-11-14 | Tooth whitening composition containing cleansing capsule |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20090049897A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013096357A1 (en) * | 2011-12-22 | 2013-06-27 | The Dial Corporation | Antiperspirant compositions and products effective to facilitate preventing, removing or minimizing fabric stains and methods for making the same |
| ITMI20121083A1 (en) * | 2012-06-20 | 2013-12-21 | Pharmaday Srl | WHITENING COMPOSITION FOR TEETH |
| KR20150057727A (en) * | 2013-11-20 | 2015-05-28 | 주식회사 엘지생활건강 | Post-treatment composition for maintaining teeth-whitening effect and kit comprising the same |
| IT202000032072A1 (en) * | 2020-12-23 | 2022-06-23 | Melo S R L | CAPSULE CONTAINING A LIQUID TOOTHPASTE |
-
2007
- 2007-11-14 KR KR1020070116252A patent/KR20090049897A/en not_active Ceased
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013096357A1 (en) * | 2011-12-22 | 2013-06-27 | The Dial Corporation | Antiperspirant compositions and products effective to facilitate preventing, removing or minimizing fabric stains and methods for making the same |
| ITMI20121083A1 (en) * | 2012-06-20 | 2013-12-21 | Pharmaday Srl | WHITENING COMPOSITION FOR TEETH |
| KR20150057727A (en) * | 2013-11-20 | 2015-05-28 | 주식회사 엘지생활건강 | Post-treatment composition for maintaining teeth-whitening effect and kit comprising the same |
| IT202000032072A1 (en) * | 2020-12-23 | 2022-06-23 | Melo S R L | CAPSULE CONTAINING A LIQUID TOOTHPASTE |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI440472B (en) | Dentifrice composition | |
| US20030152524A1 (en) | Oral composition | |
| HUP0401682A2 (en) | Oral composition comprising fine ground natural chalk | |
| TW201521771A (en) | Tooth whitening oral care product | |
| JP2003335646A (en) | Toothpaste composition | |
| AU2002256299B2 (en) | Stable herbal dentifrice | |
| KR20090049897A (en) | Tooth whitening composition containing cleansing capsule | |
| KR20110027047A (en) | Zeolite Oral Granules and Oral Compositions Containing the Same | |
| KR100805635B1 (en) | Phase transition bad breath remover with enhanced stability | |
| KR20060123410A (en) | Capsule-containing Oral Composition | |
| KR20220041057A (en) | Solid tablets toothpaste containing silicon dioxide, sodium fluoride, pyridoxine hydrochloride and sodium pyrophosphate | |
| KR100951396B1 (en) | Toothpaste composition excellent in bad breath removal, plaque removal and antibacterial effect | |
| JP6665706B2 (en) | Tooth whitening composition and tooth whitening set | |
| KR20180072609A (en) | Solid tablets toothpaste containing silicon dioxide, sodium fluoride, pyridoxine hydrochloride and sodium pyrophosphate | |
| KR20140044639A (en) | Toothpaste composition for whitening tooth using scoria powder | |
| JP3951085B2 (en) | Dentifrice composition | |
| KR100560068B1 (en) | Method for preparing oral microcapsules and composition for oral cavity containing microcapsules prepared by the method | |
| KR20170058089A (en) | Oral composition for tooth whitening | |
| KR102715081B1 (en) | Oral composition | |
| KR101273969B1 (en) | Oral composition containing capsulated perfume powder | |
| KR101502025B1 (en) | An excellent dentifrice composition for removing dyes | |
| KR100593038B1 (en) | Tooth coating | |
| JP2000053547A (en) | Composition for oral cavity | |
| JP3511727B2 (en) | Oral composition | |
| KR101573537B1 (en) | Toothpaste composition comprising poorly water soluble dye dispersed bead |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20071114 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20120904 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20071114 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140212 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20140924 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20140212 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |